News
Quotient Sciences to Recapitalize With Global Private Equity Firm Permira
Quotient Sciences to Recapitalize With Global Private Equity Firm Permira
Quotient is your answer.
Quotient is your answer.
We are dedicated to accelerating the development of new drugs for patients around the world. We provide CRO and CDMO services including formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
-
How can I quickly achieve proof-of-concept?
Access Our ExpertiseHow can I quickly achieve proof-of-concept?
Access Our Expertise -
How do I optimize my formulation?
Access Our Formulation ExpertiseHow do I optimize my formulation?
Access Our Formulation Expertise -
How do I optimize and scale up my manufacturing process for late stage development?
Discover our Commercial CapabilitiesHow do I optimize and scale up my manufacturing process for late stage development?
Discover our Commercial Capabilities -
How do I conduct my regulatory clinical pharmacology studies?
Let Us Help YouHow do I conduct my regulatory clinical pharmacology studies?
Let Us Help You -
How do I develop age-appropriate drug products?
Explore Our Pediatric CapabilitiesHow do I develop age-appropriate drug products?
Explore Our Pediatric Capabilities
Our latest updates
Discover what’s happening at Quotient Sciences
-
Case Studies
Druggability Technologies
Druggability Technologies (DRGT) is developing DRGT-46 as a novel therapy for pain. Gabor Heltovics, CEO of DRGT, explains how Quotient Sciences enabled the rapid development, clinical assessment and commercial readiness of its DRGT- 46 product using integrated services across Quotient’s network of harmonized development and manufacturing sites in the UK and US.
-
Fact Sheet
Formulation Strategies for Poorly Soluble Molecules
With nearly 30 years of experience, Quotient has established a broad suite of technologies and formulation approaches to address these complex solubility challenges. Our approach allows us to dramatically speed up the optimization of your drug products to improve oral bioavailability.